Skip to content

Discontinued — last reported Q2 '24

CapEx at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$347M+33.5%
Immunome logo
ImmunomeIMNM
$3M-18.1%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0-100%
Celcuity logo
CelcuityCELC
$249K+315%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$2K-104%
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-7.6%
Enterprise value$973.78M-5.3%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Geron’s 10-Q, filed August 8, 2024, on SEC EDGAR. View the filing →

Ask your AI about Geron's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's capex?
Geron (GERN) reported capex of $206K in Q2 2024.
How has Geron's capex changed year-over-year?
Geron's capex increased by 2.0% year-over-year, from $202K to $206K.
What is the long-term trend for Geron's capex?
Over 2 years (2021 to 2023), Geron's capex has grown at a 100.2% compound annual growth rate (CAGR), from $207K to $830K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.